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Background: Improved knowledge regarding antimicrobial use in Ghana is needed to reduce antimicrobial re-
sistance (AMR). This includes point prevalence studies (PPSs) in hospitals. Objectives were to: (i) provide baseline
data in two hospitals [Keta Municipal Hospital (KMH) and Ghana Police Hospital (GPH)] and identify priorities for
improvement; (ii) assess the feasibility of conducting PPSs; and (iii) compare results with other studies.
Methods: Standard PPS design using the Global PPS paper forms, subsequently transferred to their template.
Training undertaken by the Scottish team. Quality indicators included: rationale for use; stop/review dates; and
guideline compliance.
Results: Prevalence of antibiotic use was 65.0% in GPH and 82.0% in KMH. Penicillins and other b-lactam antibi-
otics were the most frequently prescribed in both hospitals, with third-generation cephalosporins mainly used
in GPH. Antibiotic treatment was mainly empirical and commonly administered intravenously, duration was
generally short with timely oral switching and infections were mainly community acquired. Encouragingly,
there was good documentation of the indications for antibiotic use in both hospitals and 50.0%–66.7% guideline
compliance (although for many indications no guideline existed). In addition, almost all prescribed antibiotics
had stop dates and there were no missed doses. The duration of use for surgical prophylaxis was generally more
than 1 day (69.0% in GPH and 77.0% in KMH).
Conclusions: These two hospitals were the first in Ghana to use the Global PPS system. We found the PPS
was feasible, relatively rapid and achieved with limited training. Targets for improvement identified included re-
duction of broad-spectrum antibiotics and duration of treatment.
Introduction
Unnecessary use of antibiotics is a significant and modifiable driver
for antimicrobial resistance (AMR), associated with increased mor-
bidity and mortality1 as well as cost.2–6 AMR is of particular concern
in low- and middle-income countries (LMICs), due to recent
marked increases in antimicrobial utilization.7–10 Rising AMR rates
have resulted in regional, national and global initiatives to improve
future antibiotic use through implementation of antimicrobial
stewardship programmes (ASPs),11–19 with variable implementa-
tion and outcomes in LMICs due to limited resources.17,20–25
Inappropriate use of antimicrobials in hospitals is widely
reported,21,26–35 exacerbated by high rates of HIV, TB and malaria
in sub-Saharan African countries,21,36 coupled with variable
diagnostic resources. Lack of equipment and funding models for
diagnostics leads to empirical antibiotic use without culture and
susceptibility testing. To improve hospitals’ antimicrobial use,
VC The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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LMICs have developed national action plans (NAPs) with key ele-
ments of surveillance data,12,21,28 national standard treatment
guidelines (NSTGs)16,37 and quality indicators focused on limiting
the use of broad-spectrum agents.38–41 Awareness raising via
Drugs and Therapeutics Committees (DTCs) and education of
healthcare staff17,34,42–46 are particularly important as there is
variable knowledge of AMR amongst clinicians and managers.47–51
A key target is reducing the use of WHO ‘Watch and Reserve’ cat-
egory antibiotics13 to preserve their activity and promote recom-
mended ‘Access’ category agents for the majority of infections.
In Ghana, understanding of antimicrobial utilization patterns is
required to support recent policy intentions.52–54 The Ghanaian
Ministry of Health has developed NSTGs, including those for the
management of common infections, and has launched a 5 year
NAP (2017–21).55,56 The NAP covers improving knowledge of AMR,
establishing surveillance of antimicrobial consumption, optimizing
antimicrobial use and supporting sustainable investment in AMR
reduction.
Several studies in Ghana have evaluated the use of antimicro-
bials in hospitals, as well as physicians’ knowledge and attitudes
towards AMR.33,57–60 These studies show a high prevalence of anti-
biotic use, long treatment durations and high use of broad-
spectrum agents, coupled with a lack of awareness of AMR.
Following a Fleming Fund AMR summit61 and utilizing the
Commonwealth Partnerships for Antimicrobial Stewardship
(CwPAMS),62 actions from the Ghanaian NAP63 will be progressed
to accelerate development of ASPs. In the absence of continuous
audit data or comprehensive surveillance data, point prevalence
surveys (PPSs) are an established methodology to assess and
monitor antimicrobial prescribing in hospitals.30,31,64–66
Consequently, an initial CwPAMS activity led by a team from the
Scottish Antimicrobial Prescribing Group (SAPG) was to support a
PPS in one small urban hospital and one small rural hospital using
the Global PPS system (GPPSS).22,67 The objectives were to firstly
provide baseline data for each hospital and identify priorities for
improvement to support antimicrobial stewardship (AMS).
Secondly, to assess the feasibility of PPSs using a standardized tool
with respect to the manpower needed following concerns in other
LMICs.21,31,68 Thirdly, to compare results with other hospitals in
Ghana involved in the CwPAMS initiative, with other sub-Saharan
African countries and beyond through the GPPSS. The findings will
inform bespoke multiprofessional training aimed at changing
behaviours amongst staff in each hospital and future quality im-
provement programmes as part of local ASPs.
Methods
Study design and settings
The PPS was conducted in May 2019 using the GPPSS methodology.28,69
The two hospitals were Keta Municipal Hospital (KMH), a 110 bed govern-
ment hospital in the rural Volta district of Ghana, and the Ghana Police
Hospital (GPH), a 100 bed hospital in the capital city, Accra. KMH has six
wards serving adult and paediatric medical populations, gynaecological
surgery and obstetrics and is staffed by 273 temporary and permanent
staff. GPH provides healthcare for police officers and their families but also
serves the local population.58,70 The case mix in GPH is similar to KMH ex-
cept there are additional facilities for specialist surgery and orthopaedics.
GPH has 175 core clinical staff.70
Training and data collection
Training on using the GPPSS data collection forms was undertaken by J.S.,
R.A.S. and R.M., based on their experience with SAPG in Scotland.71,72 Three
healthcare professionals (either a pharmacist, a pharmacist technician or a
nurse) were trained in each hospital to facilitate working. This was done in
pairs of one UK and one Ghanaian professional to collect the PPS data. Local
ethics approval and data collection was coordinated by the local pharmacy
leads (D.K.A. and I.A.S.).
The detailed GPPSS methodology is explained elsewhere.28 All inpa-
tients that had stayed overnight and remained on the ward at 08:00 on the
day of the survey were included. Data were collected only from those
patients who were receiving at least one antimicrobial for treatment or
prophylaxis (medical or surgical) at the time of the survey. Antimicrobials
included were Anatomical Therapeutic Chemical (ATC) J codes (anti-infec-
tives for systemic use): J01(antibacterials), J02 (antimycotics), J04 (antimy-
cobacterials) and J05 (antivirals).73 Exclusion criteria included short-stay
patients (not admitted as an inpatient), those discharged before 08:00 on
the day of the survey and those attending outpatient specialist clinics.
Data were collected using GPPSS paper forms and transferred to
the online GPPSS. Ward data included specialty, bed capacity and
number of admitted patients. Patient data included age, gender, reason
for antimicrobial prescribing, prescribed antimicrobials and dosage
regimen, and causative microorganisms if available. Only information
from the patients’ notes were included in the study. There was no con-
tact with healthcare professional staff to clarify the clinical information
collected to improve its accuracy as this could be a focus of future
quality improvement programmes.
Surgical prophylaxis included any antimicrobial administered to prevent
surgical-site infections (SSIs) and medical prophylaxis was defined as the
use of antibiotics to prevent infections in patients with non-surgical condi-
tions.21,28 Infections were considered as community-acquired infections
(CAIs) if symptoms of infection were present on admission or appeared
,48 h after admission and as healthcare-associated infection (HAI) if
symptoms appeared 48 h or more after admission, based on review of
patients’ notes.28,31,33
Antimicrobial utilization and quality indicators
Antimicrobial utilization was stratified by ward type (adults and paediatrics,
surgical, obstetric/gynaecological and medical), antimicrobial class—ATC
classification,73 by CAI or HAI and by treatment or prophylaxis.
Antimicrobial utilization was assessed against agreed quality indica-
tors based on the GPPSS and other studies.21,31,32,68,74,75 These included:
indication for antimicrobial use documented in the patient notes; com-
pliance with guidelines for documented indication (where guidance was
available); stop or review date for antimicrobial use documented in
the notes (and medicine chart); whether antimicrobial prescription was
empiric or targeted based on an identified pathogen; and duration
of surgical prophylaxis. The guidelines used were the seventh edition of
the NSTG of Ghana.76
Antimicrobial utilization in the two hospitals was compared against
each other, with other African countries in the Global PPS28 and with other
hospitals in Ghana67,68 and sub-Saharan African countries (Botswana,
Kenya, Nigeria and South Africa).21,32,35,57,59
Ethics
Formal ethics approval was not required at either hospital as there was no
direct patient contact and all data was anonymized. Local DTCs supported
the surveys and the medical superintendent and local management
team in each hospital granted clinical permission before commencement
of the PPS.
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Results
Data were collected from prescription charts and patient notes
in all wards over 2 h on a single day in each hospital. Review and
discussion of the data and comparison of prescriptions against
available guidelines took place between all data collectors over an
additional 2 h in each hospital. The Lead Pharmacist at each
hospital (D.K.A. and I.A.S.) entered data onto the GPPSS online site.
In GPH, work to realign ward designations and address other issues
with the GPPSS was required over 2 days then data entry took a
further 7 h. In KMH, there was similar realignment of ward destina-
tions followed by data entry, carried out during the course of
1 week.
A number of general observations not specified within the
GPPSS methodology were noted separately. There was a low
prevalence of known HIV-positive patients (one patient in each
hospital) and only three patients (all in KMH) being treated for TB,
no patients were observed with a record of penicillin allergy and no
patients were being treated presumptively for infection with MRSA.
Prevalence of antimicrobial use
The overall prevalence of antibiotic use was 65.0% in GPH and
82.0% in KMH. Prevalence rates ranged from 46.7% to 100.0%, de-
pending on the clinical specialty and patient population (Table 1).
Rates of antimicrobial utilization were similar in adult medical
wards (57.1%, 55.6%) and in adult surgical wards (46.7%, 50.0%)
in GPH and KMH, respectively. More paediatric patients in KMH
received antimicrobials (100.0%) than in GPH (76.9%).
Antimicrobial prescribing
Penicillins and other b-lactam antibiotics were the most frequently
prescribed antibiotics in both hospitals, with combinations of
penicillins with a b-lactam inhibitor (co-amoxiclav) the most com-
monly prescribed b-lactam antibiotic (Figure 1). Patterns of use of
second- and third-generation cephalosporins varied between
the two hospitals, with GPH using mainly third-generation agents
(82.6%) while KPH used mainly second-generation agents
(63.3%). Neither hospital had any prescriptions for carbapenems.
In both hospitals, antibiotics were commonly administered
intravenously and the use of more than one antibiotic concurrently
was also common (Table 2). Neonates were excluded from this
data analysis as there were only three, all in GPH.
Indication for prescribing
Antimicrobials were predominantly used for CAI rather than HAI in
GPH and solely for CAI in KMH. All but one prescription (at GPH) was
empirical rather than targeted in both hospitals. Use of antibiotics
for medical and surgical prophylaxis varied between the two hospi-
tals (Table 3). The types of infections treated were similar across
both hospitals but in KMH there were more non-severe respiratory
tract infections: upper respiratory tract infections (URTIs); ear, nose
and throat infections; and bronchitis.
Antimicrobial quality indicators
There were some differences in the quality indicators between
the two hospitals (Table 4) with overall good documentation of the
indication for antibiotic administration in the patients’ notes in
both hospitals. For many indications, guideline compliance could
not be assessed as they were not included in the NSTGs. Where a
guideline was available, compliance with the choice of agent
was50% in both hospitals for both medical and surgical patients.
No treatment was based on microbiology data in GPH and it
was only used for one patient in KMH (2.2%). Culture and suscepti-
bility testing is not covered by the national insurance scheme, so
patients have to pay for these investigations.
Duration of surgical prophylaxis was typically more than 1 day,
with no single-dose prophylaxis in either hospital. In 69.0% of
patients in GPH, prophylaxis lasted.1 day and in 77.0% of patients
in KMH, prophylaxis lasted.1 day.
Discussion
Key findings included, firstly, that the PPS was feasible in both
hospitals and was achieved with limited resources and minimal
training of a multidisciplinary team including pharmacy techni-
cians and nurses. In each hospital, six healthcare workers spent
approximately 2 h on training and orientation, 4 h on data collec-
tion and validation then the lead pharmacist in each hospital spent
a further 12–15 h checking and entering the data into the online
system. It is likely that repeat PPSs will take less time as staff will
be familiar with the process. It is envisaged that eventually direct
electronic data collection may be considered, which will reduce
data entry time further. This is important information given limited
resources of time, available personnel and monies in LMICs. We ac-
knowledge that both hospitals in Ghana had fewer inpatients
than in the recently published PPS in Botswana, which took 3 to
Table 1. Percentage of overall antimicrobial prevalence by hospital and type of ward
Adult Paediatric
total AMW ASW total PMW PSW NMW
GPH, % (n)a 57.1 (49) 73.7 (19) 46.7 (30) 76.9 (10) 77.8 (9) 100.0 (1) 100.0 (3)
KMH, % (n)a 55.6 (90) 56.6 (76) 50.0 (14) 100.0 (11) 100.0 (11) 0 0
Africa, Global PPS (%)b (70 hospitals) 64.2 63.9 59.0 79.4 99.4 77.9 85.7
Adult total, overall antimicrobial prevalence in adult wards; AMW, adult medical ward; ASW, adult surgical ward; paediatric total, overall antimicrobial
prevalence in wards admitting children; PMW, paediatric medical ward; PSW, paediatric surgical ward; NMW, neonatal medical ward.
aResults are shown as percentage antimicrobial prevalence (n, number of treated patients).
bBased on a total of 70 hospitals.
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5 days in their district hospitals using one or two data collectors
and 10 days in a large referral hospital using two data collectors.21
In Pakistan, data from wards in each hospital were collected over 2
to 4 weeks.31 In South Africa, following considerable time taken
with their previous paper-based PPS system, an App has been
developed to speed up data collection and analysis.68 The GPPSS
facilitates online real-time data entry but, for those new to PPSs,
paper forms support learning and build confidence amongst data
collectors. It is difficult to quantify the time required for a PPS as its
feasibility depends on several factors including the maturity of
ASPs, availability of staff with dedicated time for data collection
and the ease of finding information in clinical systems. In the
UK64,65 and across Europe, PPSs and ASPs are well established
whereas in LMICs this journey is just beginning.
We acknowledge the limitations of a single PPS in that it cannot
show trends and reasons for particular prescribing practices may
reflect the particular staff behaviours on the day of data collection.
However, this work is part of a larger project that will explore these
factors. As some ward-based staff may have been aware that the
team from Scotland were coming to support data collection it is
possible this could have influenced prescribing practice.
The prevalence of antibiotic use (GPH 65.0%, KMH 82.0%) is
similar to in two studies from two hospitals in Botswana (70.6%)21
and in Kenya (67.7%)32 but higher than in two studies from two
hospitals in South Africa (31.0% and 38.5%).67,68 This compares
with 50.0% for the 12 participating hospitals from five African
countries in the 2015 GPPSS study.28 There were low rates of HIV
and TB in the two hospitals in Ghana compared with Botswana,
where at least 40% of inpatients in their PPS had HIV and over 25%
had TB.21 The comparatively high prevalence of antibiotic use in
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Figure 1. Details of antibiotics used.
Table 2. Key prescription patterns across the two hospitals
Percentage (n) with this characteristic
Characteristic GPH KMH
IV therapy 68.6 (24) 55.9 (33)
Multiple antibiotic diagnosis 38.5 (15) 33.8 (22)
Multiple antibiotic patient 54.3 (19) 44.1 (26)
Multiple antibiotic diagnosis is defined as patients receiving .1 antibiotic
for a single diagnosis. Multiple antibiotic patient is defined as receiving
.1 antibiotic at the patient level.
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GPH and KMH will be explored further during forthcoming education
and quality improvement sessions focused on developing ASPs.
There appeared to be fewer antibiotic options available in KMH
versus GPH, which may reflect availability and supply issues in
more remote rural settings reported in other LMIC countries.77–80
This may lead to a greater reliance on broader-spectrum antibiot-
ics, as seen in the differing use of b-lactam/b-lactam inhibitor
products between the two sites. Both hospitals had significant use
of cephalosporins (GPH 24.0% and KMH 27.0% of total antibiotics
used). GPH used more third-generation cephalosporins while KMH
used more from the second generation. All except first-generation
cephalosporins are in the WHO ‘Watch’ category of antibiotics so
use should be limited.81,82 There was low use of fluoroquinolones
in both hospitals (6.6% in GPH and 3.4% in KMH), which is similar to
the African hospitals in the GPPSS study and Botswana.21,28
The promotion of narrower-spectrum antibiotics, particularly for
respiratory tract infections and urinary tract infections (UTIs), is a
key focus for global stewardship by the WHO in their AwaRe classi-
fication within the Essential Medicines List.81,82 Promotion of the
use of WHO ‘Access’ category antibiotics for these infections is
key for ASPs to limit the use of broad-spectrum agents with their
associated potential for driving AMR.
A key performance indicator for the CwPAMS work is the propor-
tion of broad-spectrum antibiotics based on the GPPSS categoriza-
tion. The proportion was similar in both hospitals (GPH 46.0%,
KMH 46.6%) and largely due to high cephalosporin use.
It was also encouraging to see good documentation of indica-
tions for antibiotic use in both hospitals (Table 4) and recording of
the duration of antibiotic treatment in the notes and medicine
chart. This mirrors findings in a PPS study in South Africa (only 5.6%
of prescriptions had no indication recorded)68 and is better than
the African countries in the GPPSS study where compliance was
only 70.4%.28 There appeared to be no missed doses of antibiotics,
which is contrary to findings in Botswana.21 This may be due to the
high number of nursing staff in each ward and their level of respon-
sibility for patient care, particularly in KMH where there are few
medical staff.
It was also encouraging to see an automatic stop for IV antibi-
otics at 48 h following high use of IV administration initially
(Table 2), with review and represcribing if required. This is seen as a
valuable initiative in both hospitals as this limits the unnecessary
prolongation of IV therapy and consequently should reduce the
risk of IV-related issues, such as phlebitis, and free up nursing time
as well as limiting costs. Practice in these hospitals appears to
contrast with a lack of review dates and IV-to-oral switching in
other sub-Saharan African countries28,68 and may serve as an ex-
emplar to other hospitals in Ghana and more widely within Africa.
Another positive observation in both hospitals was that the dur-
ation of oral antibiotics was documented on the medicine chart
and usually also in the patient notes in both hospitals. However,
the duration of oral therapy was usually 1 week, irrespective of
prior IV therapy or indication. This is a concern as there is growing
evidence for most acute bacterial infections that ‘shorter is better’
due to lower rates of adverse events including AMR, shorter length
Table 3. Summary of indications and specific diagnosis associated with
antibiotic use
Percentage (n) with characteristic
Characteristic GPH KMH
Indication for antibiotic use
CAI
total 79.5 (35) 100 (80)
empirical 100 (35) 98.8 (79)
targeted 0 1.2 (1)
HAI
total 20.5 (9) 0
empirical 100 (9) 0
targeted 0 0
prophylactic use
medical 40.9 (9) 27.8 (5)
surgical 59.1 (13) 72.2 (13)
Top 11 infection diagnoses
skin and soft tissue 26.9 (7) 11.5 (6)
obstetric/gynaecological infections 15.4 (4) 7.7 (4)
sepsis 15.4 (4) 11.5 (6)
ear, nose and throat infections 7.7 (4)
lower UTIs 11.5 (3) 3.8 (2)
pneumonia or LRTIs 11.5 (3) 25 (13)
gastrointestinal infections 7.8 (2) 13.5 (7)
upper UTIs 7.8 (2) 3.8 (2)
URTIs 3.8 (1)
intra-abdominal sepsis 3.8 (2)
bronchitis 1.9 (1)
LRTI, lower respiratory tract infection.
Table 4. Key quality indicators for antimicrobial prescribing
GPH KMH Africa Global PPSa
Quality indicator medical surgical medical surgical medical surgical
Indication for antibiotic use recorded 100 (41) 85 (17) 88 (66) 84.5 (11) 60.8 (1839) 57.6 (1230)
Guidelines missing 46.3 (19) 70 (14) 1.3 (1) 46.2 (6) 24.1 (729) 43.9 (938)
Guideline compliant 62.5 (10) 66.7 (4) 55.4 (31) 50 (2) 55.9 (670) 61.2 (370)
Stop/review date in notes 92.7 (38) 95 (19) 98.7 (74) 100 (13) 29.1 (880) 32.4 (693)
Results are shown as percentage (n).
aCarried out in 70 hospitals.
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of stay and associated reduced costs.83 With a standard oral
course length of 7 days, even after 2 days of IV treatment, this will
be another focus of the education and quality improvement work.
We observed a lack of documentation of any allergies to antibi-
otics, which was a concern. However, on questioning, it appears
that although clinicians do ask patients about allergies these are
not routinely recognized or documented. We also did not observe
presumptive treatment for infection with MRSA and it is not known
if this was because the prevalence of MRSA is low or whether it
goes unrecognized through a lack of well-equipped diagnostic
facilities, which is commonly observed in LMICs.17,84 Low rates of
recognized MRSA infections were recorded in the GPPSS study
among the participating centres in Africa (1.2%) versus rates of
around 10% in Latin America and in Central and West Asia.28
Similarly, no patients were being treated for MDR Gram-negative
(MDRGN) infections in either hospital. However, it is unknown
whether this reflects a low prevalence or a lack of funded diagnos-
tic services and this will be followed up in future studies.
Compliance with the NSTGs was approximately 65.0% in GPH
and 55.0% in KMH, which is similar to other African countries, but
falls short of high levels (95%) established in some countries.39
This is a key area for improvement given the association with ad-
herence to national guidance and improved patient outcomes,
reduced harms and reduced length of stay.85 There were many
antibiotic prescriptions for indications for which no guidance was
available in the NSTGs. Guidance on the prevention of SSIs is not
included for many specialities within the NSTGs and the PPS data
from both hospitals showed that antibiotics were given for .1 day
in approximately 70% of cases and often prolonged for up to
7 days. This is similar to findings in Botswana where the majority of
patients in a leading tertiary hospital were given antibiotics for a
mean of 5 days post-operatively74 and in a study of neurotrauma
patients in Kenya,75 as well as in the GPPSS study where prolonged
surgical prophylaxis (.1 day) was reported in up to 86.3% of
cases.28 Current guidance advocates that antibiotic prophylaxis
should typically be given 1–2 h before surgical incision, with limited
further doses86–89 as longer duration potentially increases AMR,
side-effects and costs with no significant reduction in SSI
rates.28,74 Current practice may reflect a lack of national or local
guidance but also clinician concerns regarding the risk of infection
in a resource-poor setting following surgery. However, studies
from African countries have shown the benefits of moving to sin-
gle-dose prophylaxis without unintended consequences90 and this
will be followed up in both hospitals.
Conclusions
This study has established baseline data in these two hospitals to
support education and establishment of ASPs to improve future
antibiotic utilization. The Global PPS study proved straightforward
to undertake with support from experienced partners and there
was good engagement from hospital staff. This is important in
resource-limited settings, given some of the concerns seen in
Botswana and South Africa. Compliance with prescribing guidance
could be improved but equally important is to identify and rectify
gaps in NSTGs. A number of opportunities for improvement were
identified including developing prescribing guidance to suit local
needs, i.e. covering the common indications and promoting
shorter courses based on current evidence. While IV therapy was
commonly used, the duration was often short, which supports
early hospital discharge. Development of surgical prophylaxis guid-
ance to reflect WHO recommendations while also addressing local
concerns amongst clinicians using a behaviour-change approach
should be a priority. There is also an urgent need to improve diag-
nostics to reliably inform empirical antibiotic choices. We will be
following these up as part of ongoing programmes to support ASPs
in these two hospitals. A follow-up PPS is planned for 2020
to evaluate the impact of education and quality improvement
interventions.
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